What happens when you use very low doses for rituximab retreatment for RA? More flares, but interesting mean disease activity/B cells comparison suggest most get by fine and fewer get infections #EULAR2019 LB0010 from Nijmegen @RheumNow https://t.co/opsUMPwOFd